Foundation Medicine is a world-leading molecular insights company, connecting physicians and their patients to the latest cancer treatment approaches and making precision medicine a reality for thousands.
Better Care Today
1
Genomic Testing
Comprehensive Genomic Profiling
Our portfolio of genomic tests is the leading platform for comprehensive genomic profiling. We analyze more than 300 cancer-relevant genes across the four main classes of genomic alterations to help understand the genomic makeup of a patient's tumor.
2
Molecular Insights
Valuable Insights, Actionable Options
We help match each patient’s unique genomic profile to known targeted therapies, immunotherapies and clinical trials and offer decision support services, financial assistance, and technology solutions to help streamline patient care.
Patient Story
Dealing with cancer is not just dealing with the cancer. It’s treating the whole person.
Christine Bray, ovarian cancer survivor, shares her journey to remission after obtaining a Foundation Medicine comprehensive genomic profiling test.

Better Care Tomorrow
3
More Than Numbers
Insights, Not Just Information
Our unique knowledgebase, FoundationCore™, is one of the world's largest cancer genomic databases, with more than 200,000 anonymized patient records, designed to help researchers and biopharma companies advance precision medicine, develop new therapies, and design better trials.
4
Supporting Drug Development
The Preferred Partner to BioPharma
We partner with drug developers throughout each stage of drug research and development,
from target discovery to commercial launch. Today, we are working with more than 30
biopharma partners to accelerate new biomarker-driven treatments.
Advancing Cancer Care
Each patient’s cancer informs all those cases that will come in the future.
Learn more about how we are advancing the field with our FoundationCore-powered data analytics platform, and our groundbreaking 20,000 patient real-world research dataset.
Gaurav Singal, MD, VP Data Products & Strategy

Better Care Together
5
Collective Advances
The Power of Collaboration
By sharing our genomic data, we empower researchers on the front lines to generate new connections and insights. Today, we proudly participate in a number of sharing initiatives to accelerate research efforts.
6
Transforming Cancer Care
Cultivating an Ecosystem of Partners
Every insight we gain towards better cancer care is multiplied by a hyper-connected network of physicians, biopharma, researchers, patient advocacy organizations and world-leading medical centers. Together, we are transforming cancer care.
With a single tissue biopsy and comprehensive genomic profiling (CGP), people diagnosed with cancer have access to more information about their disease than ever before. These insights are rapidly advancing precision medicine and giving patients the chance to find the treatment most likely to benefit their specific disease.
But what about when tissue is not accessible?
Join Us in the Pursuit of Better
Find out more about genomic testing, learn more about us, or read the latest updates from our blog.